Literature DB >> 19012069

Treatment endpoints for resistant port wine stains with a 755 nm laser.

Leonid Izikson1, R Rox Anderson.   

Abstract

Laser therapy of port wine stains (PWS) resistant to pulsed dye laser is challenging and controversial. Based on the theory of selective photothermolysis, vessels in such lesions may be specifically targeted with the laser wavelength of 755 nm. There is much deeper penetration of the near-infrared light and it is difficult to visualize laser-induced changes within the deeper dermis. The recognition of an appropriate immediate endpoint response with this wavelength would be helpful. This is a clinical observations report. We present examples of an appropriate PWS tissue response endpoint based on our clinical observations in resistant PWS treated with a 755 nm laser at high fluences (40-100 J/cm(2)), 1.5-ms pulse duration, with dynamic cooling device (DCD) cooling. Mild-to-moderate PWS lightening was associated with the immediate endpoint of a transient gray color that gradually evolved into persistent deep purpura within several minutes. We also discuss the clinical endpoints that represent undertreatment and overtreatment of PWS. It is important to attain, and maintain, the correct endpoint when treating PWS with this deeply penetrating near-infrared laser at high fluences in order to (a) induce lesional lightening, and (b) avoid deep dermal burns that may produce scarring. Judicious use of the 755 nm laser can be beneficial for resistant PWS.

Entities:  

Mesh:

Year:  2009        PMID: 19012069     DOI: 10.1080/14764170802524452

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  12 in total

1.  Laser treatment for verrucous hemangioma.

Authors:  Juan Manuel Segura Palacios; Pablo Boixeda; Joana Rocha; Javier Alcántara González; Leticia Alonso Castro; Cristina de Daniel Rodríguez
Journal:  Lasers Med Sci       Date:  2012-05       Impact factor: 3.161

Review 2.  An overview of clinical and experimental treatment modalities for port wine stains.

Authors:  Jennifer K Chen; Pedram Ghasri; Guillermo Aguilar; Anne Margreet van Drooge; Albert Wolkerstorfer; Kristen M Kelly; Michal Heger
Journal:  J Am Acad Dermatol       Date:  2012-02-03       Impact factor: 11.527

3.  Pulsed dye laser double-pass treatment of patients with resistant capillary malformations.

Authors:  Ratna Rajaratnam; Sharyn A Laughlin; Denis Dudley
Journal:  Lasers Med Sci       Date:  2011-04-08       Impact factor: 3.161

4.  Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma.

Authors:  Jianming Wu; Fangyan Zhou; Yu Gao
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-09

Review 5.  Lasers for cutaneous congenital vascular lesions: a comprehensive overview and update.

Authors:  Katlein França; Anna Chacon; Jennifer Ledon; Jessica Savas; Jan Izakovic; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2012-10-24       Impact factor: 3.161

6.  Treatment of hypertrophic and resistant port wine stains with a 755 nm laser: a case series of 20 patients.

Authors:  Leonid Izikson; J Stuart Nelson; R Rox Anderson
Journal:  Lasers Surg Med       Date:  2009-08       Impact factor: 4.025

7.  Hemangiomas and vascular malformations: current theory and management.

Authors:  Gresham T Richter; Adva B Friedman
Journal:  Int J Pediatr       Date:  2012-05-07

Review 8.  Laser treatment of port-wine stains.

Authors:  Lori A Brightman; Roy G Geronemus; Kavitha K Reddy
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-01-12

9.  Societal-Perceived Health Utility of Hypertrophic Facial Port-Wine Stain and Laser Treatment.

Authors:  Alyssa Heiser; Nate Jowett; Jessica Occhiogrosso; Oren Tessler; Oon T Tan
Journal:  Facial Plast Surg Aesthet Med       Date:  2020-04-22

10.  Management of vascular anomalies: Review of institutional management algorithm.

Authors:  Lalit K Makhija; Sameek Bhattacharya
Journal:  Indian J Plast Surg       Date:  2017 May-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.